Astellas has a solid and proven track record in Urology, making it a Global Category Leader (GCL) in this field of medicine.
New medicines for use in Urology are currently under evaluation through a major R&D programme. By focusing our resources and expertise in the areas of Urology that still have unmet medical needs, Astellas leads the way in developing pioneering treatments for conditions such as Benign Prostatic Hyperplasia (BPH), Prostate Cancer and Overactive Bladder (OAB), offering hope to patients.
Through our commitment to continuing research, support and understanding, we are working to identify and develop innovative solutions to the current challenges in Urology.
NPR17018Ukb – June 2018
Learn more about our therapy areas:
Well established therapies to prevent organ rejection after transplantation
Leading research to satisfy unmet patient needs in urological conditions
Our commitment is to developing first-in-class and best-in-class therapies
Addressing the complex challenges of serious fungal and bacterial infections